do glp 1 cause blood clots Deep Vein Thrombosis (DVT) & Diabetes Foro

(14) These emerging connections between GLP-1 signaling and skeletal physiology present a biologic rationale for how GLP-1 receptor agonists have potential to not only assist in weight management, but also favorably influence bone health and remodeling

For example, a patient with type 2 diabetes on GLP-1 scheduled for hip replacement may continue the agent until 1 to 2 weeks pre-op if weight loss is modest, but stop earlier if gastroparesis or severe nausea is present

Policymakers and pharmaceutical companies must ensure affordable access through generic production and innovative pricing models

Finan, B

The prescriber's experience with metabolic medications and ongoing patient monitoring often matter more than credentials alone

Obesity medicine is moving from a single-axis view of success, weight loss, towards a more complete framework that includes physical function, metabolic quality and long-term quality of life